GSK (GSK)
NYSE: GSK
· Real-Time Price · USD
37.34
0.72 (1.97%)
At close: May 12, 2025, 3:59 PM
36.90
-1.17%
Pre-market: May 13, 2025, 07:00 AM EDT
GSK Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| Sub Total Revenue | 8.96B |
| Sub Total Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.07B | 2.66B | 3.8B | 2.39B | 2.07B | 2.61B | 2.3B | 2.27B | 2.14B | 2.44B | 2.06B | 2.07B | 2.84B | 3.26B | 2.65B | 2.64B | 2.43B | 3.16B | 2.67B | 2.71B | 2.92B | 3.44B | 2.89B | 2.59B | 2.48B | 2.62B | 2.53B | 2.46B | 2.31B | 2.53B | 2.31B | 2.38B | 2.45B | 2.71B | 2.29B | 2.17B | 2.19B | 2.5B | 1.97B | 2.54B | 2.23B |
| Selling, General, and Administrative Revenue Growth | -22.27% | -29.92% | +59.00% | +15.46% | -20.78% | +13.81% | +1.23% | +5.83% | -12.10% | +18.58% | -0.48% | -27.36% | -12.76% | +23.20% | +0.15% | +8.86% | -23.24% | +18.47% | -1.48% | -7.10% | -15.31% | +19.05% | +11.66% | +4.56% | -5.46% | +3.68% | +2.85% | +6.32% | -8.76% | +9.75% | -2.98% | -2.98% | -9.55% | +18.28% | +5.43% | -0.69% | -12.37% | +26.93% | -22.55% | +14.20% | n/a |
| Research and Development Revenue | 1.46B | 2.03B | 1.46B | 1.43B | 1.37B | 2.05B | 1.57B | 1.34B | 1.26B | 1.8B | 1.35B | 1.24B | 1.17B | 1.45B | 1.49B | 1.22B | 1.12B | 1.47B | 1.14B | 1.3B | 1.19B | 1.24B | 1.21B | 1.11B | 1.01B | 1.08B | 988M | 925M | 904M | 1.21B | 1.05B | 1.26B | 960M | 1B | 922M | 888M | 815M | 1.05B | 827M | 812M | 867M |
| Research and Development Revenue Growth | -28.02% | +39.20% | +2.17% | +4.01% | -32.99% | +30.10% | +17.45% | +6.43% | -29.88% | +33.51% | +8.37% | +6.43% | -19.41% | -2.82% | +21.93% | +9.30% | -23.95% | +28.95% | -12.38% | +9.60% | -4.51% | +3.07% | +8.36% | +10.64% | -6.51% | +8.91% | +6.81% | +2.32% | -25.23% | +15.47% | -16.90% | +31.25% | -4.29% | +8.79% | +3.83% | +8.96% | -22.68% | +27.45% | +1.85% | -6.34% | n/a |